000			02340 a2200637 4500
005			20250514070010.0
264		0	_c20040423
008			200404s 0 0 eng d
022			_a0815-9319
024	7		_a10.1046/j.1440-1746.2003.03019.x _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Robert Yung Ming
245	0	0	_aEffects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus. _h[electronic resource]
260			_bJournal of gastroenterology and hepatology _cJun 2003
300			_a630-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAmino Acid Sequence
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aAustralia
650	0	4	_aBase Sequence
650	0	4	_aCatalytic Domain _xdrug effects
650	0	4	_aCodon, Terminator _xgenetics
650	0	4	_aDNA, Viral _xgenetics
650	0	4	_aDNA-Directed DNA Polymerase _xdrug effects
650	0	4	_aDrug Resistance, Viral _xdrug effects
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenome, Viral
650	0	4	_aGenotype
650	0	4	_aHepatitis B Core Antigens _xdrug effects
650	0	4	_aHepatitis B Surface Antigens _xdrug effects
650	0	4	_aHepatitis B e Antigens _xdrug effects
650	0	4	_aHepatitis B virus _xdrug effects
650	0	4	_aHepatitis B, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPoint Mutation _xdrug effects
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPromoter Regions, Genetic _xdrug effects
650	0	4	_aProspective Studies
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aStatistics as Topic
650	0	4	_aTreatment Outcome
650	0	4	_aViral Core Proteins _xdrug effects
650	0	4	_aViral Load
700	1		_aBowden, Scott
700	1		_aDesmond, Paul Vincent
700	1		_aDean, Jo
700	1		_aLocarnini, Stephen A
773	0		_tJournal of gastroenterology and hepatology _gvol. 18 _gno. 6 _gp. 630-7
856	4	0	_uhttps://doi.org/10.1046/j.1440-1746.2003.03019.x _zAvailable from publisher's website
999			_c12541040 _d12541040